SHAFF ERIC D. (See Remarks) sold 5.0% of their position (8.75K shares) of SERES THERAPEUTICS, INC. on the open market
Open‑market sale worth $6.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/29/2024ACC: 0000950170-24-118409
Officer· See Remarks
Since Jan 2019
-8.75K
Net shares
Net seller
$6.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
27.84K acquired · 36.59K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+27.84K
Price / share
—
Trade value
—
% of position
19.1%
10/27/2024
145.99K→173.83K
Common Stock
Direct
Shares
−8.75K
Price / share
$0.69
Trade value
$6.04K
% of position
5.0%
10/28/2024
173.83K→165.08K
Total
Net shares
+19.09K
Net value
-$6.04K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/27/2024 | M · Option Exercise | +27.84K | — | — | 19.1% | 145.99K | 173.83K |
| Common Stock Direct | 10/28/2024 | S · Sale | −8.75K | $0.69 | $6.04K | 5.0% | 173.83K | 165.08K |
| Total | +19.09K | -$6.04K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
27.84K shares
Shares
−27.84K
Strike price
Held after
0.00
Exercisable
—
10/27/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock27.84K shares | 10/27/2024 | M · Option Exercise | −27.84K | — | 0.00 |